Advanced Versus Invasive Breast Cancer Risk in a Screening Population: Implications for Risk-based Prevention and Screening Strategies - Scorecard - MDSpire

Advanced Versus Invasive Breast Cancer Risk in a Screening Population: Implications for Risk-based Prevention and Screening Strategies

  • By

  • Brian L. Sprague

  • Charlotte C. Gard

  • Shuai Chen

  • Jeffrey A. Tice

  • Anna N. A. Tosteson

  • Hannah Perry

  • Christoph I. Lee

  • Diana L. Miglioretti

  • Karla Kerlikowske

  • February 18, 2026

  • 0 min

Share

Clinical Scorecard: Comparing Advanced and Invasive Breast Cancer Risk in a Screening Cohort: Insights for Risk-Based Prevention and Screening Approaches

At a Glance

CategoryDetail
ConditionBreast Cancer
Key MechanismsRisk prediction models for advanced and invasive breast cancer based on demographic and clinical factors.
Target PopulationWomen aged 40–74 undergoing mammography screening.
Care SettingBreast imaging facilities participating in BCSC registries.

Key Highlights

  • Development of BCSC advanced cancer risk model for estimating 6-year risk of stage II or greater breast cancer.
  • Risk models are more accurate for ER/PR positive cancers, which have high survival rates.
  • Advanced-stage breast cancer is linked to increased mortality, emphasizing the need for effective screening.

Guideline-Based Recommendations

Diagnosis

  • Utilize BCSC risk models to inform decision-making regarding screening and prevention.

Management

  • Consider more frequent or supplemental screening for women identified at high risk for advanced breast cancer.

Monitoring & Follow-up

  • Regularly assess risk factors and update screening strategies based on individual risk profiles.

Risks

  • Advanced breast cancer is associated with higher mortality, necessitating timely intervention.

Patient & Prescribing Data

Women aged 40–74 with no prior history of breast cancer or related conditions.

Risk stratification can guide chemoprevention and screening intervals.

Clinical Best Practices

  • Implement risk-based screening strategies to optimize early detection.
  • Incorporate demographic and clinical data into risk assessments for personalized care.

References

Original Source(s)

Related Content